Rates of upgrade to malignancy in surgical excision of intraductal papillomas of the breast: A retrospective cohort study

Breast intraductal papilloma upgrade to malignancy

Authors

Keywords:

Breast cancer, intraductal papilloma, upgrade, excision, atypia

Abstract

Background/Aim: Intraductal papillomas (IDP) of the breast, though benign, share an association with the duct epithelium, similar to some breast malignancies. Percutaneous biopsies often fail to fully characterize these lesions. The decision to perform surgical excision for IDP of the breast is frequently based on the presence of atypia observed during percutaneous biopsy. However, consensus remains lacking regarding the management of IDP of the breast without atypia. This study was undertaken to share findings on IDP, contributing to a better understanding of their nature and guiding treatment approaches.

Methods: We conducted a retrospective evaluation of data from 42 female patients diagnosed with intraductal papilloma through percutaneous biopsy, who subsequently underwent surgical excision between January 1, 2015, and August 25, 2023. Patients not diagnosed with intraductal papilloma, those with prior breast malignancy diagnoses, and those identified incidentally during other surgical procedures were excluded from the study. Data recorded included patient ages, the largest lesion diameters measured by ultrasonography, the percutaneous biopsy method (Fine needle aspiration biopsy [FNAB] or Core needle biopsy [CNB]), atypia status observed during percutaneous biopsy, histopathological features observed during surgical excision, and lesion diameter in cases where malignancy was upgraded. If ductal carcinoma in situ (DCIS) or invasive cancer was identified in the surgical excision specimen, it was classified as an upgrade.

Results: The median age of the patients was 48.5 years (range: 12.9 years). FNAB was performed in ten cases (23.8%), while CNB was used in 32 cases (76.2%). There was no significant difference in the detection of atypia when comparing FNAB and CNB (P=0.57). Eight patients (19%) were diagnosed with atypical intraductal papilloma. Among them, three patients with atypia and two patients without atypia exhibited an upgrade to malignancy. The study revealed a malignancy upgrade rate of 37.5% for IDP with atypia and 5.9% for those without atypia. Furthermore, the average age of patients with malignancy upgrades was higher than that of patients with benign lesions (P=0.02).

Conclusion: In light of the malignancies detected in cases of breast IDP, even in the absence of atypia, opting for surgical excision, particularly in older patients, can help prevent the oversight of these cancers.

Downloads

Download data is not yet available.

References

Łukasiewicz S, Czeczelewski M, Forma A, Baj J, Sitarz R, Stanisławek A. Breast Cancer-Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies-An Updated Review. Cancers (Basel). 2021 Aug 25;13(17):4287. doi: 10.3390/cancers13174287. DOI: https://doi.org/10.3390/cancers13174287

Şahin HHK, Aslan O, Şahin M. Evaluation of cancer-related deaths in Turkey between 2009-2018: An epidemiological study. J Surg Med. 2020;4(8):674-7. doi:10.28982/josam.779292 DOI: https://doi.org/10.28982/josam.779292

Lakhani SR, Ellis IO, Schnitt SJ, Tan PH, van de Vijver MJ. World Health Organization classification of tumours of the breast. 4th ed. Lyon: IARC Press, 2012.

Pareja F, Corben AD, Brennan SB, Murray MP, Bowser ZL, Jakate K, et al. Breast intraductal papillomas without atypia in radiologic-pathologic concordant core-needle biopsies: Rate of upgrade to carcinoma at excision. Cancer. 2016 Sep 15;122(18):2819-27. doi: 10.1002/cncr.30118. DOI: https://doi.org/10.1002/cncr.30118

Nayak A, Carkaci S, Gilcrease MZ, Liu P, Middleton LP, Bassett RL Jr, et al. Benign papillomas without atypia diagnosed on core needle biopsy: experience from a single institution and proposed criteria for excision. Clin Breast Cancer. 2013 Dec;13(6):439-49. doi: 10.1016/j.clbc.2013.08.007. DOI: https://doi.org/10.1016/j.clbc.2013.08.007

Swapp RE, Glazebrook KN, Jones KN, Brandts HM, Reynolds C, Visscher DW, et al. Management of benign intraductal solitary papilloma diagnosed on core needle biopsy. Ann Surg Oncol. 2013 Jun;20(6):1900-5. doi: 10.1245/s10434-012-2846-9. DOI: https://doi.org/10.1245/s10434-012-2846-9

Arora N, Hill C, Hoda SA, Rosenblatt R, Pigalarga R, Tousimis EA. Clinicopathologic features of papillary lesions on core needle biopsy of the breast predictive of malignancy. Am J Surg. 2007 Oct;194(4):444-9. doi: 10.1016/j.amjsurg.2007.07.004. DOI: https://doi.org/10.1016/j.amjsurg.2007.07.004

Shiino S, Tsuda H, Yoshida M, Jimbo K, Asaga S, Hojo T, et al. Intraductal papillomas on core biopsy can be upgraded to malignancy on subsequent excisional biopsy regardless of the presence of atypical features. Pathol Int. 2015 Jun;65(6):293-300. doi: 10.1111/pin.12285. DOI: https://doi.org/10.1111/pin.12285

Moseley T, Desai B, Whitman GJ, Robinson EK, Saunders T, Gonzalez A, et al. Benign Breast Intraductal Papillomas Without Atypia at Core Needle Biopsies: Is Surgical Excision Necessary? Ann Surg Oncol. 2021 Mar;28(3):1347-55. doi: 10.1245/s10434-020-09061-w. DOI: https://doi.org/10.1245/s10434-020-09061-w

Ahmadiyeh N, Stoleru MA, Raza S, Lester SC, Golshan M. Management of intraductal papillomas of the breast: an analysis of 129 cases and their outcome. Ann Surg Oncol. 2009 Aug;16(8):2264-9. doi: 10.1245/s10434-009-0534-1. DOI: https://doi.org/10.1245/s10434-009-0534-1

Jaffer S, Nagi C, Bleiweiss IJ. Excision is indicated for intraductal papilloma of the breast diagnosed on core needle biopsy. Cancer. 2009 Jul 1;115(13):2837-43. doi: 10.1002/cncr.24321. DOI: https://doi.org/10.1002/cncr.24321

Youk JH, Kim EK, Kwak JY, Son EJ. Atypical papilloma diagnosed by sonographically guided 14-gauge core needle biopsy of breast mass. AJR Am J Roentgenol. 2010 May;194(5):1397-402. doi: 10.2214/AJR.09.3699. DOI: https://doi.org/10.2214/AJR.09.3699

Simsir A, Waisman J, Thorner K, Cangiarella J. Mammary lesions diagnosed as “papillary” by aspiration biopsy: 70 cases with follow-up. Cancer. 2003 Jun 25;99(3):156-65. doi: 10.1002/cncr.11062. DOI: https://doi.org/10.1002/cncr.11062

Masood S, Loya A, Khalbuss W. Is core needle biopsy superior to fine-needle aspiration biopsy in the diagnosis of papillary breast lesions? Diagn Cytopathol. 2003 Jun;28(6):329-34. doi: 10.1002/dc.10251. DOI: https://doi.org/10.1002/dc.10251

Ahn SK, Han W, Moon HG, Kim MK, Noh DY, Jung BW, et al. Management of benign papilloma without atypia diagnosed at ultrasound-guided core needle biopsy: Scoring system for predicting malignancy. Eur J Surg Oncol. 2018 Jan;44(1):53-8. doi: 10.1016/j.ejso.2017.10.214. DOI: https://doi.org/10.1016/j.ejso.2017.10.214

Symbol B, Ricci A Jr. Management of intraductal papilloma without atypia of the breast diagnosed on core biopsy: Size and sampling matter. Breast J. 2018 Sep;24(5):738-42. doi: 10.1111/tbj.13052. DOI: https://doi.org/10.1111/tbj.13052

Jaffer S, Bleiweiss IJ, Nagi C. Incidental intraductal papillomas (<2 mm) of the breast diagnosed on needle core biopsy do not need to be excised. Breast J. 2013 Mar-Apr;19(2):130-3. doi: 10.1111/tbj.12073. DOI: https://doi.org/10.1111/tbj.12073

Chen P, Zhou D, Wang C, Ye G, Pan R, Zhu L. Treatment and Outcome of 341 Papillary Breast Lesions. World J Surg. 2019 Oct;43(10):2477-82. doi: 10.1007/s00268-019-05047-2. DOI: https://doi.org/10.1007/s00268-019-05047-2

Li X, Wang H, Sun Z, Fan C, Jin F, Mao X. A retrospective observational study of intraductal breast papilloma and its coexisting lesions: A real-world experience. Cancer Med. 2020 Oct;9(20):7751-62. doi: 10.1002/cam4.3308. DOI: https://doi.org/10.1002/cam4.3308

Zhang X, Liu W, Hai T, Li F. Upgrade Rate and Predictive Factors for Breast Benign Intraductal Papilloma Diagnosed at Biopsy: A Meta-Analysis. Ann Surg Oncol. 2021 Dec;28(13):8643-50. doi: 10.1245/s10434-021-10188-7. DOI: https://doi.org/10.1245/s10434-021-10188-7

Kuehner G, Darbinian J, Habel L, Axelsson K, Butler S, Chang S, et al. Benign Papillary Breast Mass Lesions: Favorable Outcomes with Surgical Excision or Imaging Surveillance. Ann Surg Oncol. 2019 Jun;26(6):1695-703. doi: 10.1245/s10434-019-07180-7. DOI: https://doi.org/10.1245/s10434-019-07180-7

Downloads

Published

2023-10-19

Issue

Section

Research Article

How to Cite

1.
Ünal Özdemir Z. Rates of upgrade to malignancy in surgical excision of intraductal papillomas of the breast: A retrospective cohort study: Breast intraductal papilloma upgrade to malignancy. J Surg Med [Internet]. 2023 Oct. 19 [cited 2024 Apr. 13];7(10):690-3. Available from: https://jsurgmed.com/article/view/7994